BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21750502)

  • 1. Prostate cancer: PSA velocity in prostate cancer screening--the debate continues.
    Borofsky MS; Makarov DV
    Nat Rev Urol; 2011 Jul; 8(8):413-4. PubMed ID: 21750502
    [No Abstract]   [Full Text] [Related]  

  • 2. Reconsidering Prostate Cancer Screening.
    Schmidt C
    J Natl Cancer Inst; 2017 Jan; 109(1):1-2. PubMed ID: 28104781
    [No Abstract]   [Full Text] [Related]  

  • 3. PSA testing beneficial for prostate cancer.
    Bagcchi S
    Lancet Oncol; 2014 Sep; 15(10):e424. PubMed ID: 25328952
    [No Abstract]   [Full Text] [Related]  

  • 4. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations against prostate cancer screening with PSA].
    Marzo-Castillejo M; Nuin-Villanueva MÁ; Vela-Vallespín C
    Aten Primaria; 2012 Jul; 44(7):377-8. PubMed ID: 22520080
    [No Abstract]   [Full Text] [Related]  

  • 6. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer: PSA update--no change yet.
    Phillips R
    Nat Rev Urol; 2014 Sep; 11(9):483. PubMed ID: 25134834
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiparametric MRI in the PSA screening era.
    George AK; Pinto PA; Rais-Bahrami S
    Biomed Res Int; 2014; 2014():465816. PubMed ID: 25250323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of recommendations against prostate cancer screening with prostate specific antigen].
    Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L
    Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747
    [No Abstract]   [Full Text] [Related]  

  • 10. Aberrant PSA glycosylation--a sweet predictor of prostate cancer.
    Gilgunn S; Conroy PJ; Saldova R; Rudd PM; O'Kennedy RJ
    Nat Rev Urol; 2013 Feb; 10(2):99-107. PubMed ID: 23318363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for prostate cancer.
    Croswell J; Shin YR
    Am Fam Physician; 2013 Feb; 87(4):283-4. PubMed ID: 23418805
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving Prostate Cancer Screening and Diagnosis: Health Policy and Biomarkers Beyond PSA.
    Patel HD; Chalfin HJ; Carter HB
    JAMA Oncol; 2016 Jul; 2(7):867-8. PubMed ID: 27031887
    [No Abstract]   [Full Text] [Related]  

  • 13. PSA screening for prostate cancer: the current controversy.
    de Koning HJ; Schröder FH
    Ann Oncol; 1998 Dec; 9(12):1293-6. PubMed ID: 9932158
    [No Abstract]   [Full Text] [Related]  

  • 14. Following Up on an Improperly Drawn Screening Test: The PSA Dilemma.
    Bergman J; Schmidt B; Leppert JT
    Am J Med; 2021 Mar; 134(3):e145-e146. PubMed ID: 33171101
    [No Abstract]   [Full Text] [Related]  

  • 15. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
    Nazim SM; Raza SJ; Ather MH
    J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.
    Morgan T; Palapattu G; Wei J
    Curr Urol Rep; 2015 Sep; 16(9):63. PubMed ID: 26169584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
    Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
    Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current results on PSA-based prostate cancer detection].
    Graefen M; Schlomm T; Steuber T; Sauter G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):312-7. PubMed ID: 24562706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer: Prudent practice optimizes screening outcomes.
    Auvinen A
    Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
    [No Abstract]   [Full Text] [Related]  

  • 20. Two-Stage Biomarker Protocols for Improving the Precision of Early Detection of Prostate Cancer.
    Barnett CL; Tomlins SA; Underwood DJ; Wei JT; Morgan TM; Montie JE; Denton BT
    Med Decis Making; 2017 Oct; 37(7):815-826. PubMed ID: 28363265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.